Biogen (BIIB) PT Lowered to $340 at Oppenheimer

October 21, 2020 4:45 PM
Oppenheimer analyst Jay Olson lowered the price target on Biogen (NASDAQ: BIIB) to $340.00 (from $360.00) while maintaining an Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change